Related Experiment Videos

The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene

H Schäfer1, A Trauzold, T Sebens

  • 11st Department of Medicine, Christian-Albrechts-University of Kiel, Germany.

Oncogene
|June 17, 1998
PubMed

Insights

The tumor suppressor protein p53 directly binds to the p22/PRG1 gene promoter, activating its transcription. This study identifies p22/PRG1 as a novel target gene regulated by p53 during cell cycle arrest and apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The early response gene p22/PRG1 is implicated in cell cycle regulation, but its precise function remains unclear.
  • The promoter region of p22/PRG1 contains a potential binding site for the tumor suppressor protein p53.

Purpose of the Study:

  • To investigate the functional interaction between p53 and the p22/PRG1 gene.
  • To determine if p53 regulates p22/PRG1 transcription.

Main Methods:

  • Gel shift assays to confirm p53 binding to the p22/PRG1 promoter.
  • Chloramphenicol acetyltransferase (CAT) reporter gene assays to assess transcriptional activity.
  • Experiments using cell lines with wild-type and temperature-sensitive mutant p53, including treatments with gamma-irradiation and doxorubicin.

Main Results:

  • p53 specifically binds to the identified p22/PRG1 promoter sequence.
  • The p22/PRG1 promoter confers p53-dependent transcriptional activity.
  • p22/PRG1 expression is induced by functional p53 in a dose- and temperature-dependent manner.
  • p22/PRG1 transcription is upregulated in parallel with p21/Waf1 following p53 activation by DNA damage.

Conclusions:

  • p53 directly activates the transcription of the p22/PRG1 gene.
  • p22/PRG1 is a novel target gene of p53-mediated transcriptional regulation.
  • p22/PRG1 is involved in p53-dependent cell cycle arrest and apoptosis pathways.

Related Concept Videos